Researchers have confirmed that microplastics accumulate in menstrual blood at concentrations higher than in amniotic fluid, raising new questions about how plastic particles interact with the female reproductive system. A study published in NanoImpact by Sharma and colleagues analyzed paired menstrual blood and amniotic fluid samples from 12 participants and found microplastics in every single sample, with six distinct types of polymers identified across both fluids.

What Did the Study Actually Find?

The research team used three different analytical techniques to identify and characterize the microplastic particles: Fourier-transform infrared spectroscopy (FTIR), Raman spectroscopy, and pyrolysis gas chromatography/mass spectrometry (GC/MS). This multi-method approach is more rigorous than previous microplastics studies, which typically relied on a single detection method.

The findings were striking. Across all samples, researchers characterized 136 total particles and identified six polymer types:

• Polyethylene terephthalate (PET): Found in clothing fibers and bottled water containers
• Polypropylene (PP): Common in food packaging and synthetic fabrics
• Polymethyl methacrylate (PMMA): Used in cosmetics and dental products
• Polyethylene (PE): A basic plastic found in many consumer goods
• Polystyrene (PS): Present in disposable cutlery, coffee-cup lids, and foam packaging
• Polycarbonate (PC): Found in reusable food containers, water dispenser jugs, and some baby bottles

The most significant finding was that menstrual blood contained higher microplastic concentrations than amniotic fluid in the same women, and polycarbonate and polystyrene were the predominant polymers detected.

Why Does Menstrual Blood Have More Microplastics Than Amniotic Fluid?

Menstrual blood is not the same as venous blood drawn from a vein. It is a mixture of blood, endometrial tissue (the lining of the uterus), and cervicovaginal fluid. The higher microplastic concentrations in menstrual blood compared to amniotic fluid in the same individuals suggest that microplastics may accumulate specifically in reproductive tissue and shed during menstruation.

This finding hints that the female reproductive tract may be a site where microplastics preferentially accumulate, though the researchers emphasize this is a hypothesis supported by preliminary data, not definitive proof. The sample size of 12 participants is small, and the study is the first of its kind to examine this question in menstrual blood specifically.

How Could Microplastics Reach Reproductive Tissue?

Researchers have identified three plausible pathways by which microplastics could accumulate in the female reproductive system. Understanding these mechanisms is important because it helps identify where exposure reduction efforts should focus.

• Systemic circulation from ingestion or inhalation: Microplastics swallowed in food or water, or inhaled from indoor dust, can cross the gut wall or lung lining and enter the bloodstream. From there, they distribute throughout the body, including to reproductive tissue. Smaller particles, particularly nanoplastics under 1 micrometer in size, cross biological barriers more easily than larger particles
• Direct exposure from period products: Pads and disposable underwear are made of synthetic polymers, and tampons and panty liners shed fibers. Independent lab testing has also found phthalates and per- and polyfluoroalkyl substances (PFAS) in some period-product samples, though whether these shed particles into vaginal tissue at meaningful rates remains unknown
• Phagocytosis and tissue lodging: Immune cells called macrophages can engulf microplastic particles and migrate to tissue. This process has been demonstrated in placental tissue, but whether it occurs in the endometrium is still being investigated

What This Study Does and Does Not Prove

It is important to understand the scope of this research. The study is a biomonitoring investigation, meaning it confirms the presence of microplastics in menstrual blood. It does not establish causal links between microplastics and reproductive health problems.

The study does not prove that microplastics in reproductive tissue cause infertility, endometriosis, or pregnancy complications at the population level. It does not show that higher microplastic loads in menstrual blood predict any specific health outcome. It also does not identify period products as the source of the microplastics, because the researchers did not track product use as an exposure variable. Finally, menstrual blood has not yet been validated as a reliable biomonitoring matrix across multiple laboratories.

What the study does accomplish is opening a significant research question: the female reproductive tract has been largely understudied in microplastics research, and this is the first evidence that reproductive tissue may be a site of microplastic accumulation in humans.

What Should People Do Right Now?

The researchers and toxicologists emphasize that this is preliminary, hypothesis-generating work. The human reproductive system has been exposed to environmental plastic for decades, and the global birth rate, while declining, is not in collapse. Most people who use disposable period products will not develop infertility because of them.

However, products in direct contact with mucous tissue for hours at a time warrant closer scrutiny than average household plastic exposure. Mucous membranes absorb chemicals more readily than skin, and period products are not consistently disclosed to consumers in the United States, creating a regulatory gap.

If you want to reduce reproductive-tract microplastic exposure, the evidence-based levers are:

• Choose reusable products: Menstrual cups and discs, as well as reusable pads, have documented materials and eliminate the need for single-use synthetic products that shed fibers
• Select organic cotton products: Organic cotton tampons and pads without synthetic top sheets reduce exposure to synthetic polymers in direct contact with tissue
• Avoid fragrance and PFAS-containing leak-proof underwear: Period underwear marketed as leak-proof often contains PFAS, chemicals used to repel liquids that have been detected in some menstrual products and are known to persist in the environment and body

What Research Questions Remain Unanswered?

The 2026 study raises several critical questions that future research must address. Does higher microplastic concentration in menstrual blood correlate with worse reproductive outcomes? Are period products themselves a source of microplastics, or do they simply pool systemic exposure in the reproductive tract? Do higher microplastic loads in pregnancy associate with preterm birth, growth restriction, or developmental outcomes? Do different polymer types pose different health risks? And can the findings be replicated across different laboratories, geographies, and demographic groups ?

These gaps are not reasons to dismiss the finding. Instead, they are reasons to follow the field carefully over the next 18 to 36 months. Two large cohort studies are reportedly underway that may help answer some of these questions.

For now, the takeaway is clear: the female reproductive system is another confirmed site of microplastic accumulation in the human body, and products in direct contact with reproductive tissue deserve regulatory attention and consumer awareness.